SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
“Year after year, the work recognized by the Rising Stars in Urology Research Award exemplifies forward-looking advancements,” remarked Steven Kaplan, MD, chair of the AUA Research Council. “Dr.